Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 110.06 M101.46 M117.01 M118.91 M112.19 M117.81 M 465.92 M Research & development —————— — Operating income 5.42 M46.77 M16.43 M20.27 M2.14 M54.27 M 93.1 M Non-Operating Income, Total 86 K150 K118 K-293 K847 K45 K 717 K Interest expense, net of interest capitalized 1.29 M1.28 M1.28 M—1.28 M1.27 M — Non-Operating Income, excl. Interest Expenses -1.29 M-1.28 M-1.28 M0-1.28 M-1.27 M -3.83 M Unusual income/expense 86 K150 K118 K-293 K847 K45 K 717 K Pretax income 6.08 M47.66 M17.37 M20.87 M3.44 M55.38 M 97.05 M Equity in earnings —————— — Taxes 1.2 M12.59 M5.15 M5.78 M1.21 M15.73 M 27.88 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 4.88 M35.07 M12.22 M15.09 M2.22 M39.65 M 69.18 M Discontinued operations —————— — Net income 4.88 M35.07 M12.22 M15.09 M2.22 M39.65 M 69.18 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 4.88 M35.07 M12.22 M15.09 M2.22 M39.65 M 69.18 M Basic earnings per share (Basic EPS) 0.030.250.090.110.020.28 0.5 Diluted earnings per share (Diluted EPS) 0.030.250.090.110.020.28 0.5 Average basic shares outstanding 140.36 M140.71 M140.83 M140.7 M140.97 M141.47 M — Diluted shares outstanding 141.09 M141.16 M141.68 M141.41 M141.74 M141.81 M — EBITDA 9.49 M50.57 M19.96 M24.5 M6.11 M56.55 M 107.13 M EBIT -2.08 M38.97 M8.2 M12.43 M-6.26 M43.81 M 58.18 M Cost of revenue 195.78 M210.21 M211.15 M225.67 M199.84 M212.82 M 849.49 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 11.36 M11.6 M11.76 M12.08 M12.37 M12.74 M 48.95 M